Our Associate Director, Dr Graeme Deuchar, will be presenting an “Overview and Real World Experience of MHRA’s PIM Designation / Early Access to Medicines Scheme” at the next TOPRA in Scotland meeting. The meeting will be held on 27 September

Since 2014, there has been a welcome recognition within Europe of the need for improved regulatory mechanisms whereby medicines being developed to target serious or life-threatening diseases that represent an unmet clinical need can be made available to patients at